Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorAnkara Etlik City Hospital

About this trial

Since early-onset preeclampsia (EOPE) is commonly associated with inadequate placentation, placental insufficiency, chronic fetal hypoxia, oxidative stress, and heightened inflammation, these pathological processes may adversely affect hippocampal neuronal development and maturation of axonal pathways such as the fornix. These mechanisms support our hypothesis that fetal fornix and hippocampus dimensions may be reduced in pregnancies complicated by EOPE, forming the scientific basis of our study.

Previous research has suggested a potential link between preeclampsia (PE) and altered neurocognitive development. However, no studies to date have specifically evaluated the relationship between EOPE and fetal fornix or hippocampus dimensions. Therefore, the objective of our study is to assess fetal fornix and hippocampus measurements in pregnant women with early-onset preeclampsia compared with healthy controls.

Eligibility criteria

Qualifiers

Women aged 18-45 years

Gestational age between 20 and 34 weeks

Diagnosis of early-onset preeclampsia (EOPE)

Singleton pregnancy

Disqualifiers

Multiple pregnancies

Presence of chronic or significant comorbid conditions other than maternal early-onset preeclampsia, including: Chronic, mental, or physical illnesses, severe renal, hepatic, or gastrointestinal acute or chronic inflammatory diseases, hyperthyroidism or hypothyroidism, chronic hypertension, type 1 or type 2 diabetes mellitus, history of polycystic ovary syndrome (PCOS), history of malignancy

Fetal congenital or chromosomal anomalies

Chronic medication use

Trial design

Treatments tested in this trial

  • FHC dimensions in EOPE and control groups

Treatment groups

84 Participants
are divided into 1 treatment group

Sponsors and collaborators